ID: ALA4168648

Max Phase: Preclinical

Molecular Formula: C22H21NO4

Molecular Weight: 363.41

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1cccc(C(=O)N(C)c2ccc(Oc3ccc(O)cc3)c(C)c2)c1

Standard InChI:  InChI=1S/C22H21NO4/c1-15-13-17(7-12-21(15)27-19-10-8-18(24)9-11-19)23(2)22(25)16-5-4-6-20(14-16)26-3/h4-14,24H,1-3H3

Standard InChI Key:  HITNKVBXPVDQIE-UHFFFAOYSA-N

Associated Targets(non-human)

Androgen Receptor 399 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 363.41Molecular Weight (Monoisotopic): 363.1471AlogP: 4.78#Rotatable Bonds: 5
Polar Surface Area: 59.00Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.70CX Basic pKa: CX LogP: 4.48CX LogD: 4.48
Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.71Np Likeness Score: -1.04

References

1. Kazui Y, Fujii S, Yamada A, Ishigami-Yuasa M, Kagechika H, Tanatani A..  (2018)  Structure-activity relationship of novel (benzoylaminophenoxy)phenol derivatives as anti-prostate cancer agents.,  26  (18): [PMID:30228001] [10.1016/j.bmc.2018.09.008]

Source